November 08, 2012 08:00 ET

Technical Analysis on Cardinal Health and Omnicare - Wholesale Drug Companies Taking Good With the Bad

NEW YORK, NY--(Marketwire - Nov 8, 2012) - Companies in the wholesale drug industry, such as Cardinal Health Inc. and Omnicare Inc., have been doing an admirable job of late. Sales for many companies in the industry have contracted in recent quarterly reports, as the impact of lower priced generics take their toll. However, earnings have not followed the same trend in some cases, as select companies have effectively cut costs and improved margins. has initiated technical analysis on Cardinal Health Inc. (NYSE: CAH) and Omnicare Inc. (NYSE: OCR) which serves the Drugs Wholesale industry. These reports are free upon registration at enthuses to bring the best from the internet under one roof, providing you with a one click opportunity to view what the market and financial researchers globally have to say about any particular bellwether stocks in any given financial environment. To be part of this community please sign up at

With the major shift from brand-to-generic drugs continuing, companies that have a diversified portfolio of products could be better equipped to deal with the continued patent expirations. A wide range of product offerings are also a plus during times of economic uncertainty, as companies do not have to rely on the success of only a handful of products. Investors looking for technical analysis on Omnicare Inc. are encouraged to use the link below 

Also working in favor of the industry is the ageing baby-boomer population. The U.S. is currently witnessing 10,000 baby boomers per day crossing the 65-year-old mark, and this trend will continue for more than fifteen years. With older people generally requiring more medical attention, the industry could be well positioned for growth moving forward. Read our technical analysis on Cardinal Health Inc. by clicking on 

About Street Bulls
STREET BULLS is committed to provide the investor community with sharp and timely trading and investing advice. Our aim is to help our readers achieve above-average returns from the markets and create wealth for themselves. Our newsletters and trading advice will provide investors with the information they need for success in today's volatile markets.

To view our disclaimer, use this link

Contact Information